Skip to main content
Premium Trial:

Request an Annual Quote

HapMap Project Solicits Proposals for One-Cent Genotypes

NEW YORK, April 19 (GenomeWeb News) - The National Institutes of Health announced Friday that it will devote $6.5 million in FY 2004 to fund another member of the International HapMap Consortium.


The newest RFA solicits research proposals for completing large-scale genotyping of at least 2.25 million SNPS in the 270 HapMap samples in less thanone year - at a total cost of $.01 or less per successful genotype - while following the established quality standards of 99.5 percent accuracy and 98 percent completeness.


The awardee will be able to choose which SNPs to genotype, but will be expected to cooperate with other HapMap groups and to release data quickly to the HapMapDataCoordinationCenter.


The expiration date on the RFA is June 26 of this year, and the anticipated award date is Sept. 17. Click here for more information.


The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.